highperformr logo

Colossal Biosciences's Overview

Total employees200
HeadquartersDallas
Founded2021

Colossal Biosciences is a groundbreaking bioscience and genetics company focused on de-extinction, species preservation, and conservation. Utilizing advanced genetic engineering and reproductive technologies, Colossal aims to revive extinct species like the Woolly Mammoth and Thylacine, and protect critically endangered species, ultimately contributing to ecosystem restoration and biodiversity.

Where is Colossal Biosciences's Headquarters?

Colossal Biosciences officeColossal Biosciences officeColossal Biosciences officeColossal Biosciences office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for research and development, operations, and corporate management. Key laboratory work for genetic engineering, embryology, and early-stage development occurs here.

Notable Features:

State-of-the-art laboratories for genomics, gene editing (CRISPR), synthetic biology, advanced sequencing facilities, and cell culture labs designed for complex de-extinction workflows.

Work Culture:

Innovative, fast-paced, and mission-driven, attracting top scientists, engineers, and business professionals passionate about breakthrough discoveries in genetics and conservation. Fosters a collaborative environment focused on solving complex biological and ecological challenges.

HQ Significance:

The Dallas HQ anchors Colossal's ambitious de-extinction projects and serves as a symbol of biotech innovation in Texas. It's central to their strategy of combining cutting-edge science with entrepreneurial execution to achieve unprecedented conservation outcomes.

Values Reflected in HQ: Innovation, ambition, scientific rigor, and a commitment to addressing global biodiversity challenges are reflected in the advanced infrastructure, dedicated research environment, and the bold mission of the company.

Location:

Colossal Biosciences operates primarily from its headquarters in Dallas, Texas, with significant research and development labs and collaborations in Boston, USA, and Melbourne, Australia. Their work inherently involves global partnerships for sample collection, ecological research, access to genetic data, and potential future rewilding efforts, reflecting the international scope of biodiversity and conservation challenges they address.

Street Address:

110 Record St

City:

Dallas

State/Province:

Texas

Country:

USA

Colossal Biosciences's Global Presence

Boston, Massachusetts, USA

Address: Specific address not publicly listed, operations are closely tied with affiliated research institutions and labs in the Boston/Cambridge biotech hub.

Taps into world-leading genomics, synthetic biology, and bioinformatics expertise centered around the Cambridge/Boston academic and biotech innovation hubs.

Melbourne, Victoria, Australia

Address: Collaborates closely with institutions like the University of Melbourne; specific Colossal-owned office/lab address is not broadly public.

Serves as the hub for the Thylacine project due to proximity to historical habitat, local scientific expertise in marsupial biology and conservation, and access to genetic material and related paleontological resources.

Buying Intent Signals for Colossal Biosciences

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Colossal Biosciences

As of April 2025, Colossal Biosciences' leadership includes:

Ben Lamm - Co-Founder & CEO
George Church, Ph.D. - Co-Founder
Sarah Richardson, Ph.D. - Chief Scientific Officer
Kent Wakeford - Chief Operating Officer
Andrew Busey - Chief Technology Officer
Dr. Eriona Hysolli - Head of Biological Sciences
Matt James - Chief Animal Officer
Peter Phillips - Chief Business & Legal Officer

Investors of Colossal Biosciences

Colossal Biosciences has been backed by several prominent investors over the years, including:

Breyer Capital
In-Q-Tel
United States Innovative Technology Fund (USIT)
Animoca Brands
Arch Venture Partners
Bold Capital Partners
Boost VC
Climate Capital
Thomas Tull (Legendary Entertainment)
Peter Diamandis (XPrize Foundation)
Winklevoss Capital
WestRiver Group
Animal Capital
Jazz Venture Partners
Discovery Land Company

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Colossal Biosciences has actively strengthened its executive team over the past year, notably appointing a new Chief Scientific Officer and a Chief Business & Legal Officer to support its rapid growth and complex scientific and commercial objectives. No major high-profile executive exits have been publicly announced during this period.

New Appointments:

Sarah Richardson, Ph.D., Dr. Sarah Richardson appointed as Chief Scientific Officer to lead Colossal's scientific strategy and research programs across all de-extinction and conservation efforts.
Peter Phillips, Peter Phillips joined Colossal as Chief Business & Legal Officer to oversee business development, partnerships, legal affairs, and corporate strategy.

Technology (Tech Stack) used by Colossal Biosciences

Discover the tools Colossal Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Colossal Biosciences Email Formats and Examples

While Colossal Biosciences does not publicly disclose its official email format, companies in the technology and bioscience sectors commonly use formats like [first_initial][last]@[domain.com] or [first].[last]@[domain.com]. For official inquiries, it is best to use the contact forms or information provided on their website.

first.last@colossal.com

Format

jane.doe@colossal.com

Example

70%

Success rate

News and media

Colossal Biosciences Press ReleaseApril 2, 2024

Colossal Biosciences Appoints Dr. Sarah Richardson as Chief Scientific Officer

Colossal Biosciences announced the appointment of Dr. Sarah Richardson as its new Chief Scientific Officer. Dr. Richardson will spearhead the company's scientific vision, strategy, and program execution across its de-extinction and conservation projects, bringing extensive experience in synthetic biology and genomics....more

PR Newswire / Colossal BiosciencesMarch 5, 2024

Colossal Biosciences Announces Investment from United States Innovative Technology Fund (USIT) to Accelerate De-Extinction and Conservation Technologies

Colossal Biosciences secured an investment from the United States Innovative Technology Fund (USIT). This funding is aimed at accelerating its pioneering work in genetic engineering and synthetic biology for species restoration and ecosystem preservation, further supporting its Series B extension....more

Colossal Biosciences Press ReleaseAugust 29, 2023

Colossal Biosciences Launches Avian Genomics Group to Accelerate Dodo De-Extinction

Colossal Biosciences announced the formation of its Avian Genomics Group. This specialized team is dedicated to advancing the genetic rescue and de-extinction of the Dodo, focusing on key breakthroughs in avian genetics, including primordial germ cell manipulation and genome editing....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Colossal Biosciences, are just a search away.